We are live on ! Find out more

280 hedge funds and large institutions have $5.81B invested in Qiagen in 2024 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 109 increasing their positions, 100 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

163% more call options, than puts

Call options by funds: $57.8M | Put options by funds: $22M

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

1% more funds holding

Funds holding: 277 → 280 (+3)

9% more repeat investments, than reductions

Existing positions increased: 109 | Existing positions reduced: 100

2% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 50

2% more capital inflows, than outflows

Capital inflows: $788M | Capital outflows: $773M

0.16% more ownership

Funds ownership: 61.27% → 61.42% (+0.16%)

Holders
280
Holders Change
+3
Holders Change %
+1.08%
% of All Funds
4.02%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
51
Increased
109
Reduced
100
Closed
50
Calls
$57.8​M
Puts
$22​M
Net Calls
+$35.8​M
Net Calls Change
+$28.6​M

QGEN Hedge Fund Activity: Q1 2024 in Review

280 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Qiagen (QGEN) for Q1 2024, worth a combined $5.81B — down 4.4% from $6.09B a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new QGEN positions and 50 closed out — a net gain of 1 holder — while 109 added to existing stakes and 100 trimmed.

The largest buyer was Nuance Investments, adding an estimated $152M. The largest seller was Goldman Sachs, exiting entirely with an estimated $113M sold.

  • 280 institutional investors held Qiagen (QGEN) as of Q1 2024, up from 277 in Q4 2023.
  • Funds reported $5.81B of Qiagen stock for Q1 2024, down 4.4% quarter-over-quarter.
  • 51 funds opened new Qiagen positions in Q1 2024 and 50 closed out, a net change of +1 holder.
  • The largest Qiagen buyer in Q1 2024 was Nuance Investments, an estimated $152M added.
  • The largest Qiagen seller in Q1 2024 was Goldman Sachs, an estimated $113M sold.

Based on aggregated 13F filings for Q1 2024.